#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Respiratory tract infection viral

Recruiting

Registered drugNo placebo

Study on Stopping Antibiotics in Adults with Viral Respiratory Infections Using Tetracyclines and Other Antibiotics

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Post procedural complication

Recruiting

Registered drug

Study of Tranexamic Acid Applied to Surgical Wounds to Prevent Bleeding Complications After Plastic Surgery in Adult Patients

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Atrial fibrillation+2

Recruiting

Registered drugNo placebo

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

HER2 positive breast cancer

Recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Aprepitant

Contact Research Centre

Multiple sclerosis

Recruiting

Registered drugNo placebo

Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

Registered drugNo placebo

Norway

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Malignant melanoma

Recruiting

Registered drugNo placebo

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Deafness neurosensory

Recruiting

Registered drugNo placebo

Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Nitrous Oxide

Contact Research Centre

Coronary artery disease

Not yet recruiting

Registered drugNo placebo

Continuing vs Stopping Acetylsalicylic Acid in Elderly Patients with Chronic Coronary Syndrome (Secondary Prevention): A Randomized Trial

Registered drugNo placebo

Norway

Participants:65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Pulmonary embolism

Not yet recruiting

Registered drugNo placebo

Reduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Alteplase

Contact Research Centre

Adenocarcinoma pancreas

Not yet recruiting

Investigational

First‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:(2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.